Insights & Innovation
Stay up to date on our latest insights, scientific research, and current events, and follow TriCore in the news.
The tight supply of technologists to fill open positions is pushing laboratories to be creative in finding answers. Memorial Sloan Kettering Cancer Center and TriCore Reference Laboratories found their answers by looking not just outward but also—and largely—inward.
With no end in sight to the lab workforce shortage, vendors aim to fill the gap
Unlike high-count monoclonal B-cell lymphocytosis, low-count MBL has a limited chance of progression to CLL and thus there is no need for follow-up. And a definitive diagnosis of T-cell large granulocytic leukemia requires demonstration of clonality. Those and other points were made in a CAP18 session on practical challenges in peripheral blood evaluation.
Marcia Woolley recognized for 30 years with TriCore
Journal of Applied Laboratory Medicine
Improving the Delivery of Healthcare through Clinical Diagnostic Insights: A Valuation of Laboratory Medicine through “Clinical Lab 2.0”
As healthcare payment and reimbursement begin to shift from a fee-for-service to a value-based model, ancillary providers including laboratories must incorporate this into their business strategy. Laboratory medicine, while continuing to support a transactional business model, should expand efforts to include translational data analytics, proving its clinical and economic valuation. Current literature in this area is limited.
Summary of webinar panel discussion with laboratory leaders regarding maximizing the strategic value of labs through solutions that provide standardization, efficiency, and cost savings, and through constant innovation.
TriCore Reference Laboratories is pleased to announce and welcome Kim Hedrick as the Vice President of Business Development.
American Healthcare Leader
TriCore Reference Laboratories wants to boost the lab’s role in healthcare, and chief financial officer Renee Ennis is helping drive that transition.
The head-turning work at UNM helped show, among other things, “that
adult ALL was so much more similar to childhood ALL than had ever been appreciated.” The
assumption that the two groups occupied different worlds “was my belief up until we first saw this,”
That work also shed light on possible ethnic differences. At the time, Dr. Willman was running a
reference laboratory and biobank for the NCI’s Children’s Oncology Group. While 80 to 90 percent
of children with ALL respond well to treatment, “It was clear to me, coming from New Mexico,
where we have a large predominance of Hispanic and American Indian children,
TriCore’s Chief Scientific Officer Named President-Elect of a National AssociationFor Immediate Release – October 9, 2018 (Albuquerque, New Mexico) – TriCore Reference Laboratories’ Chief Scientific Officer, Dr. David Grenache, has been named president-elect of the American Association for Clinical Chemistry (AACC) He was named president-elect starting in January 2019. Beginning in August 2020, he will…